References
- FukiwakeNFurusyoNKuboNIncidence of atopic dermatitis in nursery school children – a follow-up study from 2001 to 2004, Kyushu University Ishigaki Atopic Dermatitis Study (KIDS)Eur J Dermatol200616441641916935801
- TakeuchiMUedaHIncrease of atopic dermatitis (AD) in recent JapanEnvir Dermatol200072133136
- SugiuraHUmemotoNDeguchiHPrevalence of childhood and adolescent atopic dermatitis in a Japanese population: Comparison with the disease frequency examined 20 years agoActa Dermato-Venereologica19987842932949689299
- GriffithsWADWilkinsonJDChampionRHBurtonJLBurnsDABreathnachSMTopical TherapyTextbook of Dermatology6th edOxfordBlackwell Scientific Publications199835193563
- FurueMTeraoHRikihisaWClinical dose and adverse effects of topical steroids in daily management of atopic dermatitisBr J Dermatol2003148112813312534606
- SurberCItinPHBircherAJTopical corticosteroidsJ Am Acad Dermatol1995326102510307751447
- CharmanCRMorrisADWilliamsHCTopical corticosteroid phobia in patients with atopic eczemaBr J Dermatol2000142593193610809850
- DavidTJSteroid scareArch Dis Child19876298768783674940
- BewleyADermatology Working GroupExpert consensus: time for a change in the way we advise our patients to use topical corticosteroidsBr J Dermatol2008158591792018294314
- FurueMTeraoHMoroiYDosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitisJ Dermatol200431427728315187322
- Japanese FK-506 Ointment Study GroupLong-term study of FK-506 (Tacrolimus) ointment in patients with atopic dermatitis – Analysis at the time of 1-year observationRinsho Iyaku1998141024052432 [in Japanese]
- AshcroftDMDimmockPGarsideRSteinKWilliamsHCEfficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trialsBMJ2005330749051615731121
- El-BatawyMMBosseilaMAMashalyHMHafezVSTopical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysisJ Dermatol Sci2009542768719303745
- HanifinJMLingMRLangleyRBrenemanDRafalETacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacyJ Am Acad Dermatol2001441 SupplS28S3811145793
- Japanese FK-506 ointment study groupPhase III study of FK-506 (Tacrolimus) ointment in patients with atopic dermatitis-Comparison study with 0.1% alclomethasone dipropionate ointment for facial and neck lesions-Acta Dermatol (Kyoto)1997923277288 [in Japanese]
- ReitamoSVan LeentEJHoVEfficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitisJ Allergy Clin Immunol2002109353954611898004
- ReitamoSRustinMRuzickaTEfficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitisJ Allergy Clin Immunol2002109354755511898005
- Japanese FK-506 Ointment Study GroupPhase III study of FK-506 (Tacrolimus) ointment in patients with atopic dermatitis-Comparison study with 0.12% betamethasone valerate ointment for trunk and extremities lesionsNishinihon J Dermatol1997595870879 [in Japanese]
- ReitamoSWollenbergASchopfESafety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study GroupArch Dermatol20001368999100610926735
- Japanese FK-506 Ointment Study GroupLong-term study of FK-506 (Tacrolimus) ointment in patients with atopic dermatitis – Analysis at the time of completion of 2-year observationRinsho Iyaku2001176705726 [in Japanese]
- BoguniewiczMFiedlerVCRaimerSLawrenceIDLeungDYHanifinJMA randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study GroupJ Allergy Clin Immunol19981024 Pt 16376449802373
- KangSLuckyAWPariserDLawrenceIHanifinJMLong-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in childrenJ Am Acad Dermatol2001441 SupplS58S6411145796
- OtsukiMNakagawaHKawashimaMShibataYHaradaSJapanese FK-506 Ointment Study GroupEfficacy and safety of FK506 (tacrolimus) ointment in children with atopic dermatitisphase III double-blinded comparison with vehicle ointmentRinsho Iyaku2003194569595 [in Japanese]
- KawashimaMOtsukiMShibataYHaradaSNakagawaHJapanese FK-506 Ointment Study GroupLong-term study of FK506 (tacrolimus) ointment in children with atopic dermatitisRinsho Iyaku2003194597636 [in Japanese]
- OtsukiMKawashimaMHaradaSNakagawaHJapanese FK-506 Ointment Study GroupAn extension study of FK-506 (tacrolimus) ointment as a follow-up to the double-blinded comparison study in children with atopic dermatitisRinsho Iyaku2005213335360
- SoterNAFleischerABJrWebsterGFMonroeELawrenceITacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safetyAm Acad Dermatol2001441 SupplS39S46
- ReitamoSRissanenJRemitzATacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trialJ Invest Dermatol199811133963989740230
- DavidTJCambridgeGCBacterial infection in atopic eczemaArch Dis Child198661120233954415
- avidTJLongsonMHerpes simplex infection in atopic eczemaArch Dis Child19856043383434004311
- FleischerABJrLingMEichenfieldLTacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infectionsJ Am Acad Dermatol200247456255012271302
- HashizumeHYagiHOhshimaAComparable risk of herpes simplex virus infection between topical treatments with tacrolimus and corticosteroids in adults with atopic dermatitisBr J Dermatol200615461204120616704659
- ReitamoSOrtonneJPSandCEuropean Tacrolimus Ointment Study GroupLong-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative studyActa Derm Venereol200787540641217721647
- ArellanoFMWentworthCEAranaAFernándezCPaulCFRisk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitisJ Invest Dermatol2007127480881617096020
- MargolisDJHoffstadOBilkerWLack of association between exposure to topical calcineurin inhibitors and skin cancer in adultsDermatology2007214428929517460399
- McNeillAMKooJY“Unknown Risks” of non-steroid topical medications for atopic dermatitisInt J Dermatol200746665665817550573
- FleischerABJrAbramovitsWBrenemanDJaraczEUS/Canada tacrolimus ointment study groupTacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitisJ Dermatol Treat2007183151157
- HonKLLamMCLeungTFChowCMWongELeungAKAssessing itch in children with atopic dermatitis treated with tacrolimus: objective versus subjective assessmentAdv Ther20072412328
- YanJChenSLWangXLZhouWWangFSMeta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patientsPediatr Dermatol200825111712018304172
- RemitzAHarperJRustinMLong-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in childrenActa Derm Venereol2007871546117225017
- ReitamoSRustinMHarperJA 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patientsBr J Dermatol2008159494295118637898
- KruegerGGEichenfieldLGoodmanJJPharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitisJ Drugs Dermatol20076218519317373177
- ThaçiDReitamoSGonzalez EnsenatMAEuropean Tacrolimus Ointment Study GroupProactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative studyBr J Dermatol200815961348135618782319
- WollenbergAReitamoSGirolomoniGEuropean Tacrolimus Ointment Study GroupProactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointmentAllergy2008637742750
- BrenemanDFleischerABJrAbramovitsWIntermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicleJ Am Acad Dermatol200858699099918359127